
How much is a box of the Indian generic version of Surufatinib?
How much is a box of the Indian generic version of Surufatinib? Surufatinib is produced by Hutchison Whampoa in China. The purchasing price is around 4,250 yuan. Please choose a formal overseas purchasing channel to ensure the product quality.
Surufatinib is a drug used for treating neuroendocrine tumors. Neuroendocrine tumors are a rare type of malignant tumor, mainly originating from neuroendocrine cells and can occur in all organs of the body. As a multi-target tyrosine kinase inhibitor, Surufatinib suppresses the progression of neuroendocrine tumors by inhibiting tumor angiogenesis and growth. In India, there is a brand of generic drugs that produces the generic version of Surufatinib. Many patients are concerned about how much a box of this Indian generic drug costs. The following will provide a detailed explanation of this.
Overview of the Indian generic drug market
India is one of the world-famous countries for producing generic drugs. Its pharmaceutical industry is developed and has a mature generic drug market. Due to the flexibility of regulations and relatively low production costs in India, Indian generic drugs are often more cost-effective than the original research drugs, which attracts many patients from other countries to seek Indian generic drugs.
The price of the Indian generic version of Surufatinib
Currently, several pharmaceutical companies in the Indian market produce the generic version of Surufatinib, and the price is relatively low. According to market research data, the average price of the Indian generic version of Surufatinib is about 3,000 to 5,000 rupees per box, which is equivalent to about 40 to 70 US dollars. This price is much lower than that of the original research drug. Therefore, for patients who need to use Surufatinib to treat neuroendocrine tumors, the Indian generic drug is a relatively cost-effective choice.
Considerations for the quality and safety of the drug
Although the Indian generic drug market is large, the quality and safety of the drug still need to be considered when purchasing. Patients should choose the generic version of Surufatinib produced by pharmaceutical companies recognized by the Drug Controller General of India and with reliable quality. These companies usually have the GMP (Good Manufacturing Practices) certification, which is a certification that ensures the quality of drugs and that the production process complies with regulations.
Consult a doctor's opinion and pay attention to the usage method
Before deciding to purchase the Indian generic version of Surufatinib, patients should also consult a doctor's opinion. The doctor will provide appropriate guidance based on the patient's condition and individual differences and ensure the correct dosage and usage method of the drug. In addition, patients need to pay attention to the drug instruction manual and follow the drug usage guidance to ensure the safety and efficacy of the drug.
The Indian generic version of Surufatinib is a cost-effective choice for treating neuroendocrine tumors. The Indian generic drug market is developed and the price is relatively low, but when purchasing, attention should be paid to the quality and safety of the drug. It is recommended that patients consult a doctor's opinion and follow the guidance of the doctor and the drug usage instructions to ensure the safety and effectiveness of the medication.